TrialJournal of hematology & oncology2019

Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial.

Dirk Hose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.